News & Updates

Show Multimedia Only

Greater weight loss at 5 years following ring-augmented RYGB

22 Feb 2025 by

Among patients who undergo primary RYGB to treat obesity, those whose surgery is augmented with a prefabricated gastric ring lose significantly more of their initial weight at 5 years, a matched cohort study has found

Greater weight loss at 5 years following ring-augmented RYGB

22 Feb 2025

Beta-blockers as first antihypertensives tied to more cardiac events

21 Feb 2025

Initiating antihypertensive treatment with an angiotensin-converting enzyme inhibitor (ACEI), an angiotensin receptor blocker (ARB), or a calcium channel blocker (CCB) results in a comparable risk for myocardial infarction (MI), acute coronary syndrome (ACS), heart failure (HF), or stroke when compared with thiazides, reports a study. On the other hand, use of beta-blockers (BBs) tends to increase such risk.

Beta-blockers as first antihypertensives tied to more cardiac events

21 Feb 2025

Breastfeeding protects women against postpartum CVD

20 Feb 2025 by

Women who breastfeed, especially those with prior gestational diabetes mellitus (GDM), appear to have greater protection against long-term atherosclerotic cardiovascular disease (ASCVD), suggest the results of a study presented at SMFM 2025.

Breastfeeding protects women against postpartum CVD

20 Feb 2025

Postpartum diuretics use eases persistent hypertension

20 Feb 2025 by

The postpartum use of diuretics can reduce persistent hypertension in women with hypertensive disorders of pregnancy (HDP), according to the results of a systematic review and meta-analysis presented at SMFM 2025.

Postpartum diuretics use eases persistent hypertension

20 Feb 2025

NT-proBNP predicts cardiorenal complications, improves risk stratification in Chinese T2D patients

20 Feb 2025

In a recent study involving 1,993 Chinese patients with type 2 diabetes (T2D) enrolled in the Hong Kong Diabetes Biobank, researchers from the Chinese University of Hong Kong (CUHK) demonstrated promising utility of N-terminal pro–B-type natriuretic peptide (NT-proBNP) as an independent prognostic biomarker for a variety of cardiorenal complications. Notably, use of NT-proBNP with established clinical risk factors improved prediction of cardiorenal complications over clinical risk factors alone. This article summarizes these findings and highlights the potential utility of NT-proBNP in clinical practice for identification of T2D patients at risk of cardiorenal complications who may benefit from early use of more intensive, organ-protective therapies.

NT-proBNP predicts cardiorenal complications, improves risk stratification in Chinese T2D patients

20 Feb 2025

Cutaneous Warts: Diagnosis and treatment with a focus on pandemic time

20 Feb 2025

Cutaneous Warts: Diagnosis and treatment with a focus on pandemic time

20 Feb 2025

Use of an SGLT2i in a patient with cardiovascular-kidney-metabolic syndrome

20 Feb 2025 by

A 70-year-old Chinese male patient had an acute myocardial infarction (MI) at the age of 60 years and underwent a successful percutaneous coronary intervention. At the time of presentation in 2013, he had cardiovascular-kidney-metabolic (CKM) syndrome, including obesity with a body mass index (BMI) of 28 kg/m², type 2 diabetes mellitus (T2DM) with HbA_1c of 7.5 percent, chronic kidney disease (CKD) with estimated glomerular filtration rate (eGFR) of 50 mL/min/1.73 m²and urine albumin-to-creatinine ratio (UACR) of 4 mg/mmol, and heart failure with reduced ejection fraction (HFrEF) and left ventricular ejection fraction (LVEF) of 40 percent.

Use of an SGLT2i in a patient with cardiovascular-kidney-metabolic syndrome

20 Feb 2025

Does xanthelasma palpebrarum elevate dyslipedemia, CVD risk?

18 Feb 2025

The presence of xanthelasma palpebrarum (XP), yellow bumps or plaques that appear on eyelids due to cholesterol deposits, does not seem to increase the rates of dyslipidemia or cardiovascular disease (CVD), suggests a study.

Does xanthelasma palpebrarum elevate dyslipedemia, CVD risk?

18 Feb 2025

Salt substitute beneficial for stroke prevention

18 Feb 2025

Using a salt substitute consisting of 75 percent sodium chloride and 25 percent potassium chloride can safely reduce the risk of stroke recurrence and death, according to data from the Salt Substitute and Stroke Study (SSaSS) from China.

Salt substitute beneficial for stroke prevention

18 Feb 2025

Flossing your teeth may help stave off stroke

18 Feb 2025 by

Regular flossing may do more than improve oral health — it could help stave off stroke, suggests new research.

Flossing your teeth may help stave off stroke

18 Feb 2025

News & Updates

Filter by Specialty:

Specialty:

Greater weight loss at 5 years following ring-augmented RYGB

Greater weight loss at 5 years following ring-augmented RYGB

Beta-blockers as first antihypertensives tied to more cardiac events

Beta-blockers as first antihypertensives tied to more cardiac events

Breastfeeding protects women against postpartum CVD

Breastfeeding protects women against postpartum CVD

Postpartum diuretics use eases persistent hypertension

Postpartum diuretics use eases persistent hypertension

NT-proBNP predicts cardiorenal complications, improves risk stratification in Chinese T2D patients

NT-proBNP predicts cardiorenal complications, improves risk stratification in Chinese T2D patients

Cutaneous Warts: Diagnosis and treatment with a focus on pandemic time

Cutaneous Warts: Diagnosis and treatment with a focus on pandemic time

Use of an SGLT2i in a patient with cardiovascular-kidney-metabolic syndrome

Use of an SGLT2i in a patient with cardiovascular-kidney-metabolic syndrome

Does xanthelasma palpebrarum elevate dyslipedemia, CVD risk?

Does xanthelasma palpebrarum elevate dyslipedemia, CVD risk?

Salt substitute beneficial for stroke prevention

Salt substitute beneficial for stroke prevention

Flossing your teeth may help stave off stroke

Flossing your teeth may help stave off stroke